144 related articles for article (PubMed ID: 37660975)
1. On the treatment of melanoma: A mathematical model of oncolytic virotherapy.
Ramaj T; Zou X
Math Biosci; 2023 Nov; 365():109073. PubMed ID: 37660975
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.
Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
PLoS One; 2017; 12(9):e0184347. PubMed ID: 28934210
[TBL] [Abstract][Full Text] [Related]
3. Mathematical Modelling of the Interaction Between Cancer Cells and an Oncolytic Virus: Insights into the Effects of Treatment Protocols.
Jenner AL; Yun CO; Kim PS; Coster ACF
Bull Math Biol; 2018 Jun; 80(6):1615-1629. PubMed ID: 29644518
[TBL] [Abstract][Full Text] [Related]
4. A mathematical model of oncolytic virotherapy with time delay.
Wang ZZ; Guo ZM; Smith H
Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: A mathematical approach.
Almuallem N; Trucu D; Eftimie R
Math Biosci Eng; 2020 Dec; 18(1):764-799. PubMed ID: 33525118
[TBL] [Abstract][Full Text] [Related]
6. Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects.
Guo Y; Niu B; Tian JP
J Biol Dyn; 2019 Dec; 13(1):733-748. PubMed ID: 31532345
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis.
Malinzi J; Ouifki R; Eladdadi A; Torres DFM; White JKA
Math Biosci Eng; 2018 Dec; 15(6):1435-1463. PubMed ID: 30418793
[TBL] [Abstract][Full Text] [Related]
8. Multiscale moving boundary modelling of cancer interactions with a fusogenic oncolytic virus: The impact of syncytia dynamics.
Alzahrani T; Eftimie R; Trucu D
Math Biosci; 2020 May; 323():108296. PubMed ID: 31887267
[TBL] [Abstract][Full Text] [Related]
9. In silico evolutionary dynamics of tumour virotherapy.
Reis CL; Pacheco JM; Ennis MK; Dingli D
Integr Biol (Camb); 2010 Jan; 2(1):41-5. PubMed ID: 20473411
[TBL] [Abstract][Full Text] [Related]
10. Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cells.
Bhatt DK; Janzen T; Daemen T; Weissing FJ
PLoS Comput Biol; 2022 Dec; 18(12):e1010076. PubMed ID: 36473017
[TBL] [Abstract][Full Text] [Related]
11. ODE models for oncolytic virus dynamics.
Komarova NL; Wodarz D
J Theor Biol; 2010 Apr; 263(4):530-43. PubMed ID: 20085772
[TBL] [Abstract][Full Text] [Related]
12. Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches.
Wodarz D; Hofacre A; Lau JW; Sun Z; Fan H; Komarova NL
PLoS Comput Biol; 2012; 8(6):e1002547. PubMed ID: 22719239
[TBL] [Abstract][Full Text] [Related]
13. Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics.
Jenner A; Yun CO; Yoon A; Kim PS; Coster ACF
J Theor Biol; 2018 Oct; 454():41-52. PubMed ID: 29857083
[TBL] [Abstract][Full Text] [Related]
14. Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses.
Schierer S; Hesse A; Müller I; Kämpgen E; Curiel DT; Schuler G; Steinkasserer A; Nettelbeck DM
Int J Cancer; 2008 Jan; 122(1):219-29. PubMed ID: 17764070
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy.
Sherlock BD; Coster ACF
J Theor Biol; 2023 Mar; 560():111394. PubMed ID: 36572093
[TBL] [Abstract][Full Text] [Related]
16. Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay.
Zhao J; Tian JP
Bull Math Biol; 2019 Jul; 81(7):2396-2427. PubMed ID: 31089864
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a Multiple Delays Model for Treatment of Cancer with Oncolytic Virotherapy.
El Alami Laaroussi A; Hia ME; Rachik M; Ghazzali R
Comput Math Methods Med; 2019; 2019():1732815. PubMed ID: 31662784
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Virus Approved To Treat Melanoma.
Schmidt C
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 27130921
[No Abstract] [Full Text] [Related]
19. Multiscale modelling of cancer response to oncolytic viral therapy.
Alzahrani T; Eftimie R; Trucu D
Math Biosci; 2019 Apr; 310():76-95. PubMed ID: 30731098
[TBL] [Abstract][Full Text] [Related]
20. Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model.
Jenner AL; Frascoli F; Coster ACF; Kim PS
J Theor Biol; 2020 Jan; 485():110052. PubMed ID: 31626813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
